Valuation and consulting for financial reporting, federal, state and local tax, investment and risk management purposes.Valuation Advisory
NEW YORK - Duff & Phelps, the premier global valuation and corporate finance advisor, today announced that it has acquired Quantera Global Asia Holding, a leading Asia-Pacific transfer pricing advisory firm affiliated with Quantera Global. The transaction extends Duff & Phelps’ transfer pricing capabilities across Asia Pacific.
Further, the transaction adds more than 25 transfer pricing professionals to Duff & Phelps in Australia, Hong Kong, Singapore and Vietnam that can provide advice throughout the Asia-Pacific region. The Quantera Asia team complements Duff & Phelps’ existing practice and brings years of experience in the region with a comprehensive range of transfer pricing consulting services, including planning, compliance and defense.
“Duff & Phelps has been working closely with the Quantera Asia team over the past several years on numerous client engagements. This transaction is the culmination of a successful partnership, and marks an important milestone in expanding our transfer pricing capability in the Asia-Pacific region,” said Jacob Silverman, President of Duff & Phelps. “Quantera Asia is a great fit for our firm, as we share a fundamental commitment to providing exceptional client service with the highest levels of objectivity, independence and technical expertise,” added Silverman.
“Tax authorities across Asia are expanding the transfer pricing reporting requirements of multinational companies and are increasingly auditing and challenging their transfer pricing practices, said Michael Heimert, Duff & Phelps’ Global Transfer Pricing Leader. “Quantera Asia’s team will enable us to better serve our clients with operations in the region and augment our capabilities in transfer pricing compliance, planning, and controversy support.”
“We are very excited to join Duff & Phelps, having already established an excellent working relationship with their transfer pricing team in recent years,” said Douglas Fone, Managing Director and Co-founder of Quantera Asia. “Our existing clients will continue to deal with the same transfer pricing professionals, but will now benefit from the Duff & Phelps global platform which enables us to offer an even broader range of services with deeper industry and technical expertise.”
In conjunction with this transaction, Quantera Global and Duff & Phelps have entered into an alliance agreement enabling both firms to further strengthen their networks and bring increased opportunities to their respective clients on a global scale.
About Duff & Phelps
Duff & Phelps is the premier global valuation and corporate finance advisor with expertise in complex valuation, disputes and investigations, M&A, real estate, restructuring, and compliance and regulatory consulting. The firm’s more than 2,000 employees serve a diverse range of clients from offices around the world. For more information, visit www.duffandphelps.com.
M&A advisory, capital raising and secondary market advisory services in the United States are provided by Duff & Phelps Securities, LLC. Member FINRA/SIPC. Pagemill Partners is a Division of Duff & Phelps Securities, LLC. M&A advisory and capital raising services in Canada are provided by Duff & Phelps Securities Canada Ltd., a registered Exempt Market Dealer. M&A advisory and capital raising services in the United Kingdom and across Europe are provided by Duff & Phelps Securities Ltd. (DPSL), which is authorized and regulated by the Financial Conduct Authority. In Germany M&A advisory and capital raising services are also provided by Duff & Phelps GmbH, which is a Tied Agent of DPSL. Valuation Advisory Services in India are provided by Duff & Phelps India Private Limited under a category 1 merchant banker license issued by the Securities and Exchange Board of India.
has sold its Power Solutions Business to
Independent financial advisor to the board of directors of Johnson Controls
Duff & Phelps advised BioNTech AG on the collaboration deal with Pfizer
March 24-27, 2019 LA
February 25-28, 2019 Atlanta